Skip to content

Demonstration study of the TCM intervention based with 'treatment before disease onset' theory on population with high-risk of osteoporosis

Demonstration study of the TCM intervention based with 'treatment before disease onset' theory on population with high-risk of osteoporosis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003060
Enrollment
Unknown
Registered
2020-02-27
Start date
2020-02-26
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Interventions

Sponsors

Bejing University of Chinese Medicine Third Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) The population aged 40-70 years; (2) Those who have risk factors of osteoporosis; (3) Results of IOF 1 minute osteoporosis test are positive; (4) The result of BMD test is reduced(-2.5 <T-value <-1.0); (5) Those with normal or abnormal bone metabolism and biochemical indicators.

Exclusion criteria

Exclusion criteria: (1) People who are known or suspected to be allergic to the drugs of the research; (2) A variety of sports contraindications (acute stages of diseases such as heart and lung diseases, bleeding-prone diseases such as gastrointestinal bleeding); (3) Patients with osteoporosis; (4) Bone metastases from malignant tumors; (5) Long-term use of drugs that affect bone metabolism; (6) Patients who are using other intervention drugs or suffering from other diseases that may interfere with the evaluation of safety or effectiveness of the drug; (7) Patients with severe primary diseases such as cardiovascular, cerebrovascular and hematopoietic diseases, and mental illness, and those who are still taking hormones and those whose results of liver and kidney function tests are abnormal(values higher than the upper limit of normal values); (8) Women preparing for pregnancy,or pregnancy, or lactation; (9) Researchers consider it inappropriate to be selected for this trial.

Design outcomes

Primary

MeasureTime frame
Bone metabolism index;Bone mineral density;

Secondary

MeasureTime frame
Visual analogue scale;Improvements in quality of life;Improvements in quality of life;Number of falls;Balance ability test;

Countries

China

Contacts

Public ContactWeiheng Chen

Bejing University of Chinese Medicine Third Affiliated Hospital

drchenweiheng@163.com+86 13511013261

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026